Welcome to our dedicated page for Cooper news (Ticker: COO), a resource for investors and traders seeking the latest updates and insights on Cooper stock.
CooperCompanies (NYSE: COO) delivers essential updates from the forefront of medical device innovation through its CooperVision and CooperSurgical divisions. This hub provides investors and healthcare professionals with direct access to official announcements, including product developments, regulatory milestones, and strategic initiatives shaping the vision care and women's health sectors.
Find curated press releases covering earnings results, clinical trial updates, and market expansion activities. Track innovations in silicone hydrogel contact lenses and fertility treatment technologies alongside analysis of industry trends impacting COO's global operations. Our repository simplifies monitoring of key developments across 130+ countries where Cooper's life-enhancing devices serve patients and providers.
Bookmark this page for real-time updates on FDA clearances, acquisition activity, and leadership changes. Subscribe to alerts for breaking news about COO's specialty lens portfolio and reproductive health solutions maintaining its position as a medical technology leader.
CooperCompanies reported a 5% year-over-year revenue growth in Q1 fiscal 2021, reaching $680.5 million. CooperVision's revenue grew 4% to $507.0 million, while CooperSurgical increased 8% to $173.5 million. GAAP diluted EPS rose to $42.31, up from $40.49 last year. The company announced fiscal 2021 guidance, projecting total revenue between $2,800 million and $2,845 million. Operating margin improved to 20%, while free cash flow was $91.8 million. Despite positive performance, COVID-19 remains a risk factor for future operations.
CooperCompanies (NYSE: COO) will participate in the KeyBanc Life Sciences MedTech Investor Forum on March 24, 2021. Brian Andrews, the Executive Vice President and CFO, will represent the company in a virtual session starting at 1:15 PM ET. A live webcast will be accessible on Cooper's Investor Relations website, with an archived audio file available later that day. CooperCompanies is a global leader in medical devices, operating through CooperVision and CooperSurgical, and is headquartered in San Ramon, CA.
CooperCompanies (NYSE: COO) has acquired Safe Obstetric Systems, a UK-based medical device manufacturer, for approximately £37.5 million in cash, plus a potential contingent payment of up to £10 million based on future revenue growth. The acquisition centers on the Fetal Pillow®, an FDA-approved device that aids in cesarean deliveries. Generating £3.5 million in revenue in 2020, the acquisition is expected to have a neutral impact on Cooper's non-GAAP earnings per share for fiscal 2021. This move aligns with CooperSurgical's mission to enhance women's healthcare.
CooperCompanies (NYSE: COO) will participate in the Oppenheimer 31st Annual Healthcare Conference on March 17, 2021. The session, representing CooperVision, will be led by Executive Vice President and COO Daniel McBride at 1:10 PM ET. Investors can access a live webcast through CooperCompanies' Investor Relations webpage, with an archived audio replay available later that day. CooperCompanies operates globally, focusing on vision care and women's health through its divisions, CooperVision and CooperSurgical, with a workforce exceeding 12,000.
CooperCompanies (NYSE: COO) will announce its first quarter 2021 financial results on March 4, 2021, at 4:15 PM ET. Following the announcement, a conference call will take place at 5:00 PM ET to discuss the financial results and recent developments. The conference call can be accessed by dialing 855-643-4430 in the U.S. or 707-294-1332 internationally, with the passcode 'Cooper'. A replay of the call will be available until March 11, 2021. CooperCompanies operates in vision care and women's health, with a global workforce exceeding 12,000.
EssilorLuxottica and CooperCompanies have announced a joint venture to acquire SightGlass Vision, a U.S. company innovating spectacle lenses to combat myopia progression in children. This 50/50 venture aims to leverage both companies' expertise to enhance the commercialization of SightGlass Vision's lenses, complementing existing products like Essilor's Stellest lens and CooperVision's MiSight. Myopia affects 2.6 billion globally, expected to rise to 5 billion by 2050, making this collaboration essential in addressing this eye health crisis.
CooperSurgical has acquired California-based AEGEA Medical, known for its FDA-approved Mara™ Water Vapor Ablation System. This strategic acquisition enhances CooperSurgical's portfolio in women's healthcare, focusing on in-office treatments for heavy menstrual bleeding. The Mara system offers a two-minute, effective solution, demonstrated by clinical trials to improve quality of life for patients. With 99% of users reporting improved well-being, the acquisition aligns with CooperSurgical's commitment to innovative healthcare solutions.
CooperCompanies Achieves Great Place to Work Certification
On January 26, 2021, CooperCompanies announced that it has been recognized as a Great Place to Work-Certified™ organization for the third consecutive year. Employees rated the company highly for attributes such as pride, camaraderie, and respect. Notably, 91% of employees felt welcomed upon joining. President Albert White emphasized the importance of a supportive culture, while Great Place to Work highlighted Cooper's commitment to a positive employee experience. Cooper operates in the medical device sector, focusing on vision care and women’s health.
CooperCompanies (NYSE: COO) has declared a semi-annual dividend of 3 cents per share, set to be paid on February 9, 2021, to stockholders recorded by January 22, 2021. This decision aligns with the company's strategy of providing annual dividends, reflecting its commitment to shareholder returns. Cooper operates through two main units: CooperVision and CooperSurgical, focusing on vision care and women's health, respectively. With over 12,000 employees and products available in over 100 countries, CooperCompanies continues to grow in the medical device industry.
CooperCompanies (NYSE: COO) will present virtually at the J.P. Morgan Healthcare Conference on January 12, 2021, at 12:40 PM PT (3:40 PM ET). Al White, President and CEO, will represent the company during the event. Investors can access the live webcast via the Investor Relations section of CooperCompanies' website, with a replay available 24 hours post-presentation. CooperCompanies operates through two units: CooperVision, focusing on vision care, and CooperSurgical, which advances health for women and families. The company is headquartered in San Ramon, California.
FAQ
What is the current stock price of Cooper (COO)?
What is the market cap of Cooper (COO)?
